Cargando…
Financial Burden of Drugs Prescribed for Cancer-Associated Symptoms
The financial toxicity of anticancer drugs is well-documented, but little is known about the costs of drugs used to manage cancer-associated symptoms. METHODS: We reviewed relevant guidelines and compiled drugs used to manage seven cancer-associated symptoms (anorexia and cachexia, chemotherapy-indu...
Autores principales: | Gupta, Arjun, Nshuti, Leonce, Grewal, Udhayvir S., Sedhom, Ramy, Check, Devon K., Parsons, Helen M., Blaes, Anne H., Virnig, Beth A., Lustberg, Maryam B., Subbiah, Ishwaria M., Nipp, Ryan D., Dy, Sydney M., Dusetzina, Stacie B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213200/ https://www.ncbi.nlm.nih.gov/pubmed/34558297 http://dx.doi.org/10.1200/OP.21.00466 |
Ejemplares similares
-
The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up
por: Etteldorf, Andrew, et al.
Publicado: (2022) -
Price Comparison of Human and Veterinary Formulations of Common Medications
por: Haque, Waqas, et al.
Publicado: (2022) -
Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products
por: Gupta, Arjun, et al.
Publicado: (2022) -
Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates
por: Everson, Jordan, et al.
Publicado: (2020) -
Pharmacologic Interventions for Breathlessness in Patients With Advanced Cancer: A Systematic Review and Meta-analysis
por: Feliciano, Josephine L., et al.
Publicado: (2021)